Deals Shaping The Medical Industry, October 2022
Executive Summary
In Vivo's deal-making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – acquisition, alliance, or financing. This month’s column covers deals announced in October 2022. Data provided by Biomedtracker.
You may also be interested in...
Execs On The Move: New Leaders for Vyaire, Nevro, And More In May 2023
An interactive summary of recent executive-level company changes and promotions in the medical device and diagnostics sectors.
Minute Insight: Owlstone Medical’s 'Breath Biopsy' Tech Adopted By US Military
The company will create a handheld version of its FAIMS technology, to be used in rapid testing for transmissible illnesses in combat scenarios.
Illumina Appeals FTC Decision, Grail Swings And Misses
Illumina has formally appealed the FTC’s decision to block its acquisition of Grail, just days after Grail mistakenly sent letters to patients suggesting they could have cancer.